Contributions of angiotensin II and tumor necrosis factor-α to the development of renal fibrosis

American Journal of Physiology - Renal Physiology

Volumn 280, Issue 5 49-5, 2001, Pages

  Guo, Guangjie ^a   Morrissey, Jeremiah ^a   McCracken, Ruth ^a   Tolley, Timothy ^a   Liapis, Helen ^a   Klahr, Saulo ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

Interstitial volume; Myofibroblast; Tubulointerstitial fibrosis

Indexed keywords

ALPHA ACTIN; ANGIOTENSIN; ENALAPRIL; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; KIDNEY FIBROSIS; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; URETER OBSTRUCTION;

EID: 0035030918     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2001.280.5.f777     Document Type: Article

References (20)

1. Benigni A, Corna D, Maffi R, Benedetti G, Zoja C, and Remuzzi G. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy. Kidney Int 54: 353-359, 1998.
2. 1 receptors during neonatal ureteral obstruction. Am J Physiol Renal Fluid Electrolyte Physiol 268: F1117-F1123, 1995.
3. Diamond JR, Kees-Folts D, Ding G, Frye JE, and Restrepo NC. Macrophages, monocyte chemoattractant peptide-1 and TGF-β1 in experimental hydronephrosis. Am J Physiol Renal Fluid Electrolyte Physiol 266: F926-F933, 1994.
4. Eddy AA. Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 5: 1273-1287, 1994.
5. Fern RJ, Yesko CM, Thornhill BA, Kim HS, Smithies O, and Chevalier RL. Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J Clin Invest Invest. 103: 39-46, 1999.
6. Guo G, Morrissey JJ, McCracken R, Tolley T, and Klahr S. The role of TNFR1 and TNFR2 receptors in the interstitial fibrosis of obstructive nephropathy. Am J Physiol Renal Physiol 277: F766-F772, 1999.
7. Hisada Y, Sugaya T, Yamanouchi M, Uchida H, Fujimura H, Sakurai H, Fukamizu A, and Murakami K. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest 103: 627-635, 1999.
8. Hocher B, Thone-Reineke C, Rohmeiss P, Schmager F, Slowinski T, Burst V, Siegmund F, Quertermous T, Bauer C, Neumayer HH, Schleuning WD, and Theuring F. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 99: 1380-1389, 1997.
9. Ishidoya S, Morrissey JJ, McCracken R, Reyes A, and Klahr S. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 47: 1285-1294, 1995.
10. Kakinuma Y, Kawamura T, Bills T, Yoshioka T, Ichikawa. I, and Fogo A. Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 42: 46-55, 1992.
11. Kaneto H, Morrissey JJ, and Klahr S. Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44: 313-321, 1993.
12. Kaneto H, Morrissey JJ, McCracken R, Ishidoya S, Reyes AA, and Klahr S. The expression of mRNA for tumor necrosis factor α increases in the obstructed kidney of rats soon after unilateral ureteral ligation. Nephrologie 2: 161-166, 1996.
13. Kaneto H, Morrissey JJ, McCracken R, Reyes A, and Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 45: 1637-1647, 1994.
14. Klahr S and Morrissey JJ. Angiotensin II and gene expression. Am J Kidney Dis 31: 171-176, 1998.
15. Klahr S and Morrissey JJ. The role of growth factors, cytokines and vasoactive compounds in obstructive nephropathy. Semin Nephrol 18: 622-632, 1998.
16. Ma J, Nishimura H, Fogo A, Kon V, Inagami T, and Ichikawa I. Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction. Kidney Int 53: 937-44, 1998.
17. 2 receptor blockade on the pathogenesis of renal fibrosis. Am J Physiol Renal Physiol 276: F39-F45, 1999.
18. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20: 1-17, 1992.
19. Perico N, Amuchastegui SC, Colosio V, Sonzogni G, Bertani T, and Remuzzi G. Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started. J Am Soc Nephrol 5: 1139-1146, 1994.
20. Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, and Benigni A. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury. Exp Nephrol 4: 213-221, 1996.